Semnur Pharmaceuticals, Inc.

8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jul 7, 2026 8-K Shareholder vote results Jun 25, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Terminated a material agreement Apr 23, 2026 8-K Director or officer change Mar 17, 2026 10-K Fiscal year ended 2025-12-31 Feb 27, 2026 8-K Other events Dec 3, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Unregistered sale of equity; Modified rights of security holders; Changed accountants; Change in control; Director or officer change; Amended charter or bylaws; Item 5.05; Item 5.06; Regulation FD disclosure; Other events Sep 26, 2025 8-K Shareholder vote results Sep 4, 2025 8-K Entered a material agreement; Unregistered sale of equity Aug 22, 2025 10-Q Quarter ended 2025-06-30 Aug 15, 2025 8-K Other events Aug 11, 2025 8-K Entered a material agreement Jul 28, 2025 8-K Other events Jul 11, 2025 8-K Other events Jun 12, 2025 10-Q Quarter ended 2025-03-31 May 16, 2025 8-K Other events May 12, 2025 8-K Entered a material agreement Apr 22, 2025 8-K Shareholder vote results; Other events Apr 16, 2025 8-K Delisting notice or listing-rule failure Apr 9, 2025 10-K Fiscal year ended 2024-12-31 Apr 2, 2025 8-K Other events Mar 12, 2025 8-K Other events Feb 11, 2025 8-K Other events Jan 8, 2025 8-K Other events Dec 11, 2024 10-Q Quarter ended 2024-09-30 Nov 19, 2024 8-K Other events Nov 12, 2024 8-K Other events Oct 11, 2024 8-K Delisting notice or listing-rule failure Oct 7, 2024 8-K Other events Sep 12, 2024 8-K Entered a material agreement; Regulation FD disclosure Sep 5, 2024 10-Q Quarter ended 2024-06-30 Aug 19, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Other events Aug 9, 2024 8-K Changed accountants Jul 17, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Amended charter or bylaws; Shareholder vote results; Regulation FD disclosure Jul 10, 2024 8-K Regulation FD disclosure Jul 5, 2024 8-K Terminated a material agreement; Regulation FD disclosure Jun 27, 2024 10-Q Quarter ended 2024-03-31 May 22, 2024 10-K Fiscal year ended 2023-12-31 Apr 1, 2024